Contributions of Neisseria meningitidis LPS and non-LPS to proinflammatory cytokine response by Sprong, T. et al.
PDF hosted at the Radboud Repository of the Radboud University
Nijmegen
 
 
 
 
The following full text is a publisher's version.
 
 
For additional information about this publication click this link.
http://hdl.handle.net/2066/19674
 
 
 
Please be advised that this information was generated on 2017-12-05 and may be subject to
change.
Contributions of Neisseria meningitidis LPS and non-LPS to
proinflammatory cytokine response
Tom Sprong,* Nike Stikkelbroeck,* Peter van der Ley,† Liana Steeghs,† Loek van Alphen,†
Nigel Klein,‡ Mihai G. Netea,* Jos W. M. van der Meer,* and Marcel van Deuren*
*Department of Internal Medicine, University Medical Center Nijmegen, Nijmegen, and †National Institute of Public
Health and the Environment, Bilthoven, The Netherlands; and ‡Institute of Child Health, University College London
Medical School, London, United Kingdom
Abstract: To determine the relative contribution
of lipopolysaccharide (LPS) and non-LPS compo-
nents of Neisseria meningitidis to the pathogenesis
of meningococcal sepsis, this study quantitatively
compared cytokine induction by isolated LPS, wild-
type serogroup B meningococci (strain H44/76), and
LPS-deficient mutant meningococci (strain H44/
76[pLAK33]). Stimulation of human peripheral-
blood mononuclear cells with wild-type and LPS-
deficient meningococci showed that non-LPS com-
ponents of meningococci are responsible for a
substantial part of tumor necrosis factor (TNF)-a
and interleukin (IL)-1b production and virtually all
interferon (IFN)-g production. Based on tricine
sodium dodecyl sulfate-polyacrylamide gel electro-
phoresis analysis of LPS in proteinase K-treated
lysates of N. meningitidis H44/76, a quantitative
comparison was made between the cytokine-induc-
ing capacity of isolated and purified LPS and LPS-
containing meningococci. At concentrations of
>107 bacteria/mL, intact bacteria were more po-
tent cytokine inductors than equivalent amounts of
isolated LPS, and cytokine induction by non-LPS
components was additive to that by LPS. Experi-
ments with mice showed that non-LPS components
of meningococci were able to induce cytokine pro-
duction and mortality. The principal conclusion is
that non-LPS parts of N. meningitidis may play a
role in the pathogenesis of meningococcal sepsis
by inducing substantial TNF-a, IL-1b, and IFN-g
production. J. Leukoc. Biol. 70: 283–288; 2001.
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INTRODUCTION
It is generally accepted that the induction of cytokine synthesis
and the subsequent pathophysiological events during Gram-
negative septic shock are primarily elicited by the lipopoly-
saccharide (LPS) component (endotoxin) of the bacterial outer
membrane [1]. Purified LPS is able to induce a proinflamma-
tory cytokine pattern and a clinical condition that resembles, at
a first glance, the symptoms encountered in Gram-negative
septic shock. The LPS-molecule is composed of a lipid-A part
harboring its toxic properties, a saccharide part, and one or
more molecules of 2-keto-3-deoxy-octanate (KDO) connecting
the lipid-A and the saccharide part [2].
Anti-LPS strategies explored so far have failed to ameliorate
the clinical course of Gram-negative sepsis [3–6], which raises
the question whether LPS is the sole toxic element in Gram-
negative sepsis [7].
Fulminant meningococcal sepsis is considered the prototypical
human gram-negative septic shock, characterized by extremely
high endotoxin and cytokine concentrations [8–11]. Thus, the
causative bacterium Neisseria meningitidis is a suitable subject for
the study of cytokine induction by gram-negative bacteria.
Recently, a viable N. meningitidis mutant was constructed that
is devoid of LPS but still contains all other outer membrane
constituents [12]. This mutant has made it possible to assess
the cytokine-inducing potency of the non-LPS parts of this
gram-negative bacterium in a quantitative fashion.
The principal aim of the present study is to determine the
contribution of LPS and non-LPS components of N. meningi-
tidis to the pathogenesis of meningococcal sepsis. Therefore,
we compared quantitatively the cytokine production induced
by meningococcal LPS, wild-type meningococci, and LPS-
deficient meningococci.
MATERIALS AND METHODS
The wild-type serogroup B N. meningitidis H44/76 strain was isolated from
a patient with invasive meningococcal disease [13]. Meningococcal strain
H44/76[pLAK33] is a viable isogenic mutant, completely devoid of LPS in its
outer membrane. This mutant was constructed by insertional inactivation of the
lpxA gene, essential for the first committed step in biosynthesis of LPS [12, 14].
The absence of LPS in this strain was confirmed by tricine sodium dodecyl
sulfate (SDS)-polyacrylamide gel electrophoresis (TSDS-PAGE) with silver
staining of LPS [15, 16], whole-cell enzyme-linked immunosorbent assay
(ELISA) with LPS-specific monoclonal antibodies, and gas-chromatographic/
mass-spectrometric detection of LPS-specific 3-OH fatty acids [17]. Further-
more, absence of LPS activity in the pLAK33 batch suspension was confirmed
by nonreactivity in the Limulus amebocyte lysate assay. Heat-killed (1 h, 56°C)
bacteria washed in phosphate-buffered saline (PBS) were used in all experi-
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ments. The amount of bacteria in the suspensions used was measured by
spectrophotometry; an optical density (OD) of 0.2 at 620 nm appeared to be
equivalent to approximately 109 bacteria/mL.
Outer membrane complexes (OMCs) of both meningococcal strains were
prepared by sarcosyl extraction as described previously [18]. These OMCs
consist primarily of PorA (class 1), PorB (class 3), and the RmpM (class 4)
outer membrane proteins. The pLAK33 OMCs contain no LPS and express
increased amounts of an OpA protein [19], H44/76 OMCs contain 10–20%
LPS. Protein content was determined by a bicinchoninic acid assay (Pierce
Chemical Co., Rockford, IL) with bovine serum albumin as a standard.
The molecular mass of meningococcal strain H44/76 LPS is 4,044 Da [20];
one molecule of LPS contains two molecules of KDO (molecular mass, 238 Da).
LPS was isolated by the phenol/water extraction method as described by
Westphal and Jann [21]. After isolation, LPS was treated with proteinase K
(Sigma-Aldrich Co.) and with DNase and RNase (Roche Diagnostics) for
additional purification, recovered by ultracentrifugation, freeze-dried, and
solved in sterile PBS. The amount of protein contamination in this purified LPS
solution was determined by bicinchoninic acid assay. DNA and RNA contam-
ination was determined by spectrophotometry using a Genequant RNA/DNA
calculator (Pharmacia Biotech AB, Uppsala, Sweden).
The KDO content of the purified H44/76 LPS solution and of the bacterial
suspensions was measured spectrophotometrically by the method described by
Weissbach and Hurwitz [22].
TSDS-PAGE followed by silver staining of LPS was used for quantification
of LPS in N. meningitidis H44/76. Cell lysates of H44/76 meningococci were made
by suspending 1.35 3 1010 bacteria in 500 mL of SDS-buffer (7.5% glycerol, 1.25
M Tris/HCl, 1.5% SDS) and incubating this for 5 min at 100°C. Proteins in this
suspension were digested by incubation with proteinase K (0.5 mg/mL) for 4 h at
56°C [23]. Serial dilutions of purified H44/76 LPS were used as a standard. After
silver staining, the polyacrylamide gel was analyzed by densitometry.
Blood for the isolation of human peripheral blood mononuclear cells
(PBMCs) was drawn in 10-mL EDTA-anticoagulated tubes (Vacutainer Sys-
tem; Beckton Dickinson, Rutherford, NJ) from healthy volunteers. PBMCs were
isolated by density gradient centrifugation on Ficoll-Hypaque (Pharmacia
Biotech AB). The cells from the interphase were aspirated, washed three times
in sterile PBS, and resuspended in culture medium RPMI 1640 (Dutch
modification; Flows Lab, Irvine, Scotland) supplemented with L-glutamine (2
mmol), pyruvate (1 mmol), and gentamycin (50 mg/mL) and 5% freshly pooled
human serum. PBMCs (53106/well) were incubated with various stimuli in
200-mL 96-well plates (Greiner BV, Alphen a/d Rijn, The Netherlands) at
37°C and 5% CO2 for 4 and 24 h. The supernatant was obtained by centrif-
ugation and stored at 220°C until the cytokine assay was performed.
C57Bl/6J mice, obtained from the Jackson Lab (Bar Harbor, ME), were bred
in our local facility. The animals were fed standard laboratory food (Hope
Farms, Woerden, The Netherlands) and housed under specific pathogen-free
conditions; 6- to 8-week-old mice weighing 20 to 25 g were used for the
experiments. Resident peritoneal macrophages were harvested by rinsing the
peritoneal cavity aseptically with sterile PBS (4°C), 105 cells/well were incu-
bated with the different stimuli for 24 h. For lethality experiments, mice were
pretreated with galactosamine (10 mg/mouse) 30 min before the pathogen was
injected into an orbital vein.
Tumour necrosis factor a (TNF-a) and interleukin-1b (IL-1b) were deter-
mined by radioimmunoassay as described previously [24]. Interferon-g (IFN-g)
was determined by enzyme-linked immunosorbent assay with a commercially
available kit (Pelikine Compact Human IFN-g ELISA kit, Central Laboratory
of the Netherlands Red Cross, Amsterdam, The Netherlands). The lower
detection limit was 80 pg/mL for both TNF-a and IL-1b and 4 pg/mL for
IFN-g. Murine TNF-a (mTNF-a) and murine IL-1b (mIL-1b) were determined
by radioimmunoassay as described by Netea et al. [25]. Detection limits were
40 pg/mL for mTNF-a and 20 pg/mL for mIL-1b.
Results were compared by a Wilcoxson-Mann-Whitney test for unpaired,
nonparametrical data. Spearman’s rank correlation coefficient was calculated
to quantify the correlation between study parameters. P values of .0.05 were
considered significant.
RESULTS
Quantification of LPS in N. meningitidis H44/76
bacteria
To enable a quantitative comparison between cytokine induc-
tion by isolated LPS and H44/76 meningococci, the purity of N.
meningitidis H44/76 LPS was analyzed, and the amount of LPS
in N. meningitidis H44/76 bacteria was determined.
Protein contamination in the purified H44/76 LPS was
,2.5%, and DNA and RNA contamination was 3.0% and
2.7%, respectively. This indicates that the H44/76 LPS used
was at least 92% pure. The amount of KDO that was detected
in 1 mg/mL of H44/76 LPS solution was 0.091 mg/mL. As-
suming an average molecular mass for LPS of 4,044 Da, the
amount of LPS in this solution based on the KDO assay was
(0.09134,044)/(23832) ’ 0.8 mg of LPS/mL.
TSDS-PAGE with silver stain of LPS was used to determine
the amount of LPS in cell lysates of N. meningitidis H44/76
(Fig. 1) [16, 23, 26]. Density analysis of the silver stain of LPS
in different dilutions of cell lysates of N. meningitidis H44/76
bacteria and of serial dilutions of purified LPS showed that 7 3
105 bacteria contain approximately 1 ng of LPS.
As an alternative approach to determine the amount of LPS
in the LPS-containing H44/76 strain, the amount of KDO
detected in the LPS-deficient pLAK33 suspension was sub-
tracted from that in the H44/76 suspension. Because the only
difference between these isogenic strains is the presence of
LPS, the difference in KDO content reflects LPS-associated
KDO. In this way, it was calculated that 10 3 105 H44/76
bacteria contain approximately 1 ng of LPS, a result rather
similar to that obtained by TSDS-PAGE analysis.
Quantitative comparison of cytokine induction
The dose-response relationship of meningococcal LPS, wild-
type N. meningitidis H44/76, and LPS-deficient N. meningiti-
Fig. 1. TSDS-PAGE silver staining of
0.1 mg (lane 1), 0.19 mg (lane 2), 0.39
mg (lane 3), and 0.77 mg (lane 4) of
purified H44/76 LPS and LPS in pro-
teinase K-treated lysates of 53108
(lane 5) and 2.5 3 108 (lane 6) N.
meningitidis H44/76 bacteria. Insert:
Standard curve as calculated by linear
regression for contour density (OD3mm2)
of the purified LPS samples. Contour
density of the lysates corresponds with
0.7 mg of LPS in sample 5 and 0.34 mg
of LPS in sample 6.
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dis pLAK33 for cytokine production by PBMCs after 24 h is
shown in Figure 2. In this figure the x-axis was calibrated for
LPS together with the number of H44/76 bacteria that con-
tained an equivalent amount of LPS, based on the above-
presented TSDS-PAGE results. Therefore, the effect of all
three stimuli could be compared quantitatively.
It can be seen that at concentrations higher than 107 bacteria/
mL, LPS-containing meningococci were more potent inductors of
TNF-a and IL-1b than equivalent amounts of isolated LPS
(P,0.05). Below these concentrations, LPS was a more potent
inductor of TNF-a and IL-1b production. LPS-deficient pLAK33
meningococci were able to induce substantial amounts of TNF-a,
IL-1b, and IFN-g production. For TNF-a and IL-1b, approxi-
mately 10-fold-higher amounts of LPS-deficient bacteria were
required to induce the same level of cytokine production as that in
wild-type bacteria. Of interest, significant IFN-g production oc-
curred after stimulation with both the wild-type and the LPS-
deficient meningococci, but only minute amounts of IFN-g were
produced after stimulation with isolated LPS (P,0.05). Experi-
ments (n58) performed with 4 h of incubation showed a similar
pattern for TNF-a and IL-1b (data not shown).
To assess whether the IFN-g production induced by LPS-
containing or LPS-deficient meningococci is secondary to the
TNF-a or IL-1b production, a series of induction experiments
with 6 3 108/mL of H44/76 and pLAK33 bacteria was per-
formed with cells from 30 donors. In these experiments, the
TNF-a and IL-1b production appeared to be correlated
(r50.061 (P,0.01) and r50.70 (P,0.001) for wild-type and
LPS-deficient meningococci, respectively). However, IFN-g
production did not correlate with the TNF-a or IL-1b produc-
tion values for r between 20.12 and 0.22 (P5not significant).
In addition, it could be seen that IFN-g production showed a
striking interindividual variety [range, 56–7,800 pg/mL (me-
dian, 555 pg/mL) and 40–6800 pg/mL (median, 660 pg/mL)
for H44/76 and pLAK33 bacteria, respectively]. Thus, IFN-g
is probably not produced in response to TNF-a or IL-1b, and
the individual response in IFN-g production after stimulation
with meningococci differs considerably.
The time course for TNF-a and IL-1b production by PBMCs
showed a similar pattern for meningococcal LPS and both
meningococcal strains. In brief, TNF-a became detectable
after 2 h, reached a maximum after 8 h, and declined thereafter
whereas IL-1b was detectable after 4 h and reached a plateau
phase after 12 h (data not shown).
The relative contribution of non-LPS structures to the total
induction of TNF-a and IL-1b induction by N. meningitidis
was assessed in a series of combination experiments. In these
experiments, meningococci were supplemented with approxi-
mately the same amount of LPS as present in the wild-type
strain. Figure 3 shows the results of this experiment for IL-1b
after 24 h of incubation. It can be seen that IL-1b production
induced by LPS-deficient bacteria was approximately half of
that induced by LPS-containing bacteria, whereas after addi-
tion of LPS, the IL-1b induction by LPS-deficient bacteria was
restored to the level of LPS-containing bacteria. Results for
TNF-a and for experiments (n55) with 4 h of incubation
showed a similar pattern (data not shown). This additive effect
of LPS to the non-LPS-induced cytokine synthesis suggests
that both stimuli may use different pathways for the induction
of TNF-a and IL-1b.
Cytokine induction by outer membrane
complexes
To determine whether the non-LPS components responsible for
cytokine induction reside in the outer membrane, cytokine
induction by OMCs isolated from the wild-type H44/76 me-
ningococci and the LPS-deficient pLAK 33 meningococci was
assessed. Figure 4 shows the results for IL-1b after 24 h of
incubation. It appeared that the wild-type H44/76 OMCs were
potent inductors of cytokine synthesis, whereas the cytokine-
inducing capacity of pLAK33 OMCs was 1,000- to 10,000-fold
less than that of H44/76 OMCs. Results for TNF-a and for
Fig. 2. Production of TNF-a (left panel),
iL-1b (middle panel), and IFN-g (right
panel) after 24 h by human PBMCs stimu-
lated with different concentrations of
H44/76 LPS (F), wild-type H44/76 menin-
gococci (n ), and LPS-deficient H44/
76[pLAK33] meningococci (h). Values on
the x-axis are calibrated for H44/76 LPS
and the number of H44/76 bacteria that
contain the same amount of LPS (1 ng of
LPS ’ 73105 bacteria). Mean values 6 SE
are presented (n55).
Fig. 3. IL-1b production after 24 h by
human PBMCs stimulated with 6 3 106
or 6 3 108/mL of wild-type H44/76
meningococci (open bars) (n525), the
same amounts of LPS-deficient H44/
76[pLAK33] meningococci (light-gray
bars) (n525), or the same amounts of
LPS-deficient pLAK33 meningococci
substituted with equivalent amounts of
LPS (0.0085 and 0.85 mg/mL, respec-
tively) as present in wild-type H44/76
meningococci (dark-gray bars) (n55).
Mean values are presented 6 SE. **,
P , .01 compared with wild-type me-
ningococci as well as LPS-deficient me-
ningococci substituted with LPS.
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experiments (n55) with 4 h of incubation showed a similar
pattern (data not shown). Taken together these results indicate
that the outer membrane components present in OMCs like
PorA, PorB, RmpM, or OpA make a minimal contribution to
cytokine induction.
Cytokine induction and lethality in mice
In mice we assessed whether the observed cytokine induction
by non-LPS components of meningococci coincides with the
capacity to provoke disease. Results in Table 1 indicate that
LPS-deficient meningococci were able to induce cytokine pro-
duction in murine peritoneal macrophages in vitro. Table 2
demonstrates that LPS-deficient meningococci were able to
induce lethality in galactosamine-sensitized mice in vivo. The
dose needed for LPS-deficient meningococci to induce mortal-
ity was approximately 100-fold higher than for LPS-containing
meningococci.
DISCUSSION
The principal finding of the present study is that LPS is not the
sole cytokine-inducing element of N. meningitidis. Using a
meningococcal mutant completely devoid of LPS, it was shown
that non-LPS components of this bacterium were responsible
for a substantial part of the TNF-a and IL-1b production, that
non-LPS components induced IFN-g, and that non-LPS parts
could provoke disease. Based on TSDS-PAGE analysis of LPS
in proteinase K-treated cell lysates of N. meningitidis H44/76,
a quantitative comparison between the cytokine-inducing ca-
pacity of LPS and that of LPS-containing bacteria became
possible. It was shown that concentrations of .107/mL of
bacteria were more potent inductors of cytokine synthesis than
equivalent amounts of isolated LPS and that cytokine induction
by non-LPS components was additive to that by LPS. Further-
more, it was demonstrated that the non-LPS components re-
sponsible for the cytokine induction do not reside in sarcosyl-
extracted outer membrane complexes.
Non-LPS components of bacteria can induce cytokine pro-
duction [7], as has been shown by experiments with gram-
positive bacteria [27–31] and with various isolated elements of
these bacteria like peptidoglycan [32–34], lipopeptides [28],
lipoproteins [28], lipoteichoic acid [35], and capsular polysac-
charides [36]. However, so far studies trying to assess quanti-
tatively the contribution of these non-LPS structures to cyto-
kine induction by gram-negative bacteria were hampered by
the inevitable copresence of LPS, outflanking the cytokine
induction by non-LPS structures. To circumvent this problem
we used a meningococcal mutant that is entirely deficient of
LPS. With this strain we demonstrated that approximately half
the amount of TNF-a and IL-1b induced by meningococci in
human PBMCs or murine peritoneal macrophages was elicited
by non-LPS structures. Similarly, LPS-deficient meningococci
could cause lethal disease in galactosamine-pretreated mice,
albeit the dosages of LPS-deficient meningococci required to
induce mortality were approximately 100-fold higher than for
wild-type meningococci.
TNF-a, IL-1b, and IFN-g are pivotal mediators in the
pathogenesis of Gram-negative septic shock. After infusion of
LPS in human volunteers or primates, TNF-a and IL-1b ap-
pear within 1 to 2 h [37], but no IFN-g seems to appear [38].
However, after the infusion of whole bacteria, IFN-g is induced
and can be detected in the circulatory system after 6–8 h [38,
39]. During meningococcal infections, IFN-g is increased in
plasma or cerebrospinal fluid and correlates with the severity of
disease [40, 41]. In our in vitro study, meningococcal LPS
stimulated only minimal IFN-g production, whereas both LPS-
containing and LPS-deficient bacteria induced significant
amounts of IFN-g. In addition, IFN-g was not produced in
response to TNF-a or IL-1b, which indicates that non-LPS
components of meningococci were primarily responsible for
IFN-g induction. Because the primary source of IFN-g is the
lymphocyte and marked differences occur between individuals,
it is tempting to speculate that certain non-LPS components of
meningococci can act as superantigens.
In this study we used the widely employed KDO assay to
determine the amount of LPS in the H44/76 LPS preparation
[22, 42, 43]. With this method (0.8/0.92) 3 100% (i.e., 85%)
Fig. 4. Production of IL-1b after 24 h
by human PBMCs stimulated with dif-
ferent concentrations of OMCs isolated
from the wild-type H44/76 meningo-
cocci (n ) containing 10–20% LPS and
from mutant H44/76[pLAK33] menin-
gococci (h) devoid of LPS. OMC con-
centration is expressed as protein con-
tent in micrograms per milliliter. Mean
values (n55) are presented 6 SE.
TABLE 1. Production of mTNF-a and mIL-1a after 24 h by
Murine Peritoneal Macrophages Stimulated with Wild-Type
H44/76 Meningococci and LPS-Deficient
H44/76[pLAK33] Meningococci
Stimulus (dosage)
mTNF-a
(ng/mL)
mIL-1a
(ng/mL)
N. meningitidis H44/76 (23109/mL) 1.85 6 0.39 4.67 6 1.09
N. meningitidis H44/76[pLAK33]
(23109/mL) 0.86 6 0.54 1.96 6 0.77
Mean data 6 SD are presented [n54 for H44/76 meningococci; n55 for
H44/76[pLAK33] meningococci].
TABLE 2. Mortality at 24 h (%) in Mice Pretreated with
Galactosamine after i.v. Injection of Heat-Killed N. meningitidis
Strain
Mortality (%) at dosage of
bacteria/mouse
107 108 109
N. meningitidis H44/76 60 100 100
N. meningitidis H44/76[pLAK33] 0 0 60
Each group contained five animals.
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of the LPS was detected. Limitations of this assay are conver-
sion of a fraction of KDO during acid hydrolysis to entities inert
to the thiobarbituric acid reaction and incomplete hydrolysis,
both leading to an underestimation of the amount of KDO. On
the other hand, contaminants in the LPS may coreact in the
assay, which leads to overestimation of the amount of LPS [44,
45]. The relatively accurate yield of KDO in the present study
showed that these limitations of the KDO assay are likely to be
of minor importance for determination of H44/76 LPS.
By TSDS-PAGE analysis of LPS in lysates of N. meningitidis
H44/76, the amount of LPS in H44/76 bacteria was deter-
mined. It appears that 7 3 105 bacteria corresponded to
approximately 1 ng of LPS, which fits rather well with the
results obtained by KDO analysis in H44/76 and pLAK33
bacteria. This estimate is in good accordance with reported
estimates of 1 ng of LPS for 105 bacteria with Escherichia coli
[1, 46–50], taking into account that the MW of meningococcal
LPS is 2- to 10-fold lower than that of E. coli LPS. In addition,
our estimate compares fairly well to clinical data of Brandtzaeg
et al. [51], Mariani-Kurkdjian et al. [52], and Bingen et al. [53],
who detected LPS values up to 500 ng/mL and bacterial
numbers up to 5 3 108 CFU/mL in cerebrospinal fluid during
meningococcal meningitis.
Based on the estimate that 7 3 105 bacteria correspond to 1
ng of LPS, we could compare the cytokine-inducing potency of
isolated LPS with that of meningococci containing the same
amount of LPS. It was found that at concentrations below 107
bacteria/mL or equivalent amounts of LPS, LPS induced more
TNF-a and IL-1b, but at higher concentrations, complete
meningococci were more potent. Because at these higher con-
centrations the TNF-a- and IL-1b-inducing capacities of LPS-
deficient meningococci increased in a parallel fashion, the
higher activity of bacteria at these higher concentrations is
likely to have been caused by the non-LPS components of the
bacterium.
Fulminant meningococcal sepsis is characterized by high
plasma concentrations of endotoxin that range from 0.75 to 170
ng/mL [8, 10, 54–56]. Based on our estimation of 1 ng of LPS
per 7 3 105 bacteria, the reported range of endotoxin concen-
trations corresponds to 5 3 105 to 1.2 3 108 bacteria/mL. We
speculate that strategies designed to block LPS-induced cyto-
kine synthesis alone are of limited value, because at this
degree of bacteremia, a substantial part of the proinflammatory
cytokine response is elicited by non-LPS parts of the menin-
gococcus [56a].
Because several outer membrane proteins of N. meningitidis
are known to interact with human cell receptors [57, 58], we
examined whether sarcosyl-extracted outermembrane complexes
are able to induce cytokine production. LPS-deficient OMCs
primarily composed of the major outer membrane proteins PorA,
PorB, RmpM, and OpA did not induce cytokines. Thus, other
meningococcal components not retained after sarcosyl extraction,
for instance certain lipoproteins, chromosomal DNA, the polysac-
charide capsule [59], or the peptidoglycan cell wall [32–34], must
have been responsible for the observed cytokine induction by the
LPS-deficient mutant. Further research is needed to identify
which of the non-LPS components are responsible for cytokine
induction and to quantify their relative contribution to the patho-
genesis of invasive meningococcal disease.
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